Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-16 | 2024-06 | -9.91 | -19.28 | -9.37 | -94.55% |
2024-05-13 | 2024-03 | -16.61 | -5.75 | 10.86 | 65.38% |
2024-04-01 | 2023-12 | -49.84 | -27.48 | 22.36 | 44.86% |
2023-11-09 | 2023-09 | -47.6 | -58.47 | -10.87 | -22.84% |
2023-08-10 | 2023-06 | -88.82 | -85.62 | 3.2 | 3.60% |
2023-05-08 | 2023-03 | -79.87 | -103.83 | -23.96 | -30.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-31 | Alliance Global Partners | Upgrade | Buy | Buy |
2023-06-01 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-08-30 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-08-10 | Alliance Global Partners | Upgrade | Buy | Buy |
2021-02-24 | Alliance Global Partners | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2020-08-12 | BAGGER RICHARD H | Director | 10.00K | Purchase |
2020-08-19 | BELL MARGARET SMITH | Director | 5.39K | Purchase |
2021-05-24 | GOODMAN DANIEL WINTNER M.D. | Director | 5.00K | Purchase |
2022-06-28 | LEDERMAN SETH | Chief Executive Officer | 0.00 | Purchase |
2018-06-24 | MARIO ERNEST B | Director | 0.00 | Purchase |
2018-06-13 | MORRIS JESSICA EDGAR | Chief Operating Officer | 1.64K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 398.75K | 630.03K | 2.24% |
2023-06-29 | Renaissance Technologies, LLC | 211.42K | 334.05K | 1.19% |
2023-06-29 | Geode Capital Management, LLC | 85.37K | 134.88K | 0.48% |
2023-06-29 | Acadian Asset Management. LLC | 68.74K | 108.61K | 0.39% |
2023-06-29 | Blackrock Inc. | 48.34K | 76.38K | 0.27% |
2023-06-29 | Raymond James & Associates, Inc. | 44.36K | 70.10K | 0.25% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 297.30K | 469.74K | 1.67% |
2023-06-29 | Vanguard Extended Market Index Fund | 100.84K | 159.33K | 0.57% |
2023-05-30 | Fidelity Extended Market Index Fund | 49.98K | 89.47K | 0.28% |
2023-05-30 | Fidelity Total Market Index Fund | 13.51K | 24.18K | 0.08% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.14K | 16.35K | 0.05% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 6.31K | 6.10K | 0.04% |
Split | Date |
---|---|
1 : 32 | 2024-06-10 |
4 : 25 | 2023-05-10 |
1 : 32 | 2022-05-17 |
1 : 10 | 2019-11-01 |
1 : 10 | 2018-11-28 |
1 : 10 | 2017-03-17 |
-
This will rebound not worried
-
-
Still hold 6k shares this will bounce.. whole biotech is down due to Russia
-
-
Great buy guys
-
Poop Tnxp
-
I kept this big bag of TNXP for a long time, for me today is the time to drop it with a big loss of money, this company it just have no future. Look at the performance over the last 5 years.its just disappoint, I truly believe that the stock will go up again, but the competition is to big for them, and they don’t even know to promote their products,
-
1.05s look like a good support bounces off that a couple times
-
-
In 10 August is the Tnxp shareholders meting, we will see then what is going up,
-
Tnxp has big potential, they have a good research team, the only problem is that the liders of the company at imbeciles and very bad at promoting their products
-
-
This company have a very big potential, they have already a lot of contracts and partnerships, also they are buying 40000 feet facility where they can produce and deposit millions of vaccines ,the only problem is that they are very bad at promoting themselves,
-
-
-
-
-
Conference in 15 minutes
-
Hold, BIG conference will start soon
-
Taking the lead: Tonix Pharmaceuticals Holding Corp (TNXP)
news.google.com • -
Examining Tonix Pharmaceuticals Holding Corp (TNXP) stock is warranted
news.google.com •